ArticleHaemophilia : the official journal of the World Federation of Hemophilia2022

A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures.

Miguel Escobar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.